1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Kinase Inhibitors Market, By Type
5.1 Introduction
5.2 Receptor Tyrosine Kinase Inhibitors
5.2.1 Platelet-derived Growth Factor Receptors (PDGFR)
5.2.2 Vascular Endothelial Growth Factor Receptor (VEGFR)
5.2.3 Anaplastic lymphoma kinase (ALK)
5.2.4 Human Epidermal Growth Factor Receptor 2 (HER2)
5.2.5 Estimated Glomerular Filtration Rate (EGFR)
5.3 Non-receptor Tyrosine Kinase Inhibitors
5.3.1 Mesenchymal Epithelial Transition Growth Factor (c-MET)
5.3.2 Spleen Tyrosine Kinase (SYK) Inhibitors
5.3.3 Bruton’s Tyrosine Kinase (BTK) Inhibitors
5.3.4 BCR-ABL
5.3.5 Janus Kinase (JAK) Inhibitor
5.4 Angiogenesis Inhibitors
5.5 Protein Kinase C Inhibitors
5.6 RHO Kinase Inhibitors
5.7 Multikinase inhibitors
5.8 Serine/Threonine Kinase Inhibitors
5.9 Tyrosin kinase inhibitors (TKI)
5.10 Threonine kinase inhibitor
5.11 mTOR Kinase Inhibitors
5.12 BRAF Inhibitors
5.13 Cyclin Dependant Kinase Inhibitor
5.14 Aurora Kinase Inhibitors
5.15 MAP/MEK Kinase Inhibitors
5.16 Humanized Monoclonal Antibody
5.17 Chimeric Monoclonal Antibody
5.18 JNK Inhibitors
5.19 PI3K Inhibitors
5.20 Other Types
5.20.1 Monoclonal Antibody Kinase Inhibitor
6 Global Kinase Inhibitors Market, By Distribution Channel
6.1 Introduction
6.2 Independent Pharmacies
6.3 Hospital Pharmacies
6.4 Online Pharmacies
7 Global Kinase Inhibitors Market, By Application
7.1 Introduction
7.2 Inflammatory Diseases
7.3 Oncology
7.3.1 Lung Cancer
7.3.2 Renal Cell Cancer
7.3.3 Breast Cancer
8 Global Kinase Inhibitors Market, By End User
8.1 Introduction
8.2 Scientific Research Labs
8.3 Hospitals
8.4 Academic Institutes
8.5 Healthcare Facilities
8.6 Pharmaceutical Companies
8.7 Private and Government Research Institutes
9 Global Kinase Inhibitors Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Меrсk Ѕеrоnо Ѕа
11.2 Nоvаrtіѕ Іntеrnаtіоnаl Аg
11.3 Incyte Corporation
11.4 Glaxo SmithKline
11.5 Суtrх Соrроrаtіоn
11.6 Оѕі Рhаrmасеutісаlѕ Llс
11.7 AstraZeneca, Eisai Co., Ltd.
11.8 Bristol-Myers Squibb
11.9 Bayer AG
11.10 Pfizer Inc.
11.11 Takeda Pharmaceutical Company Limited
11.12 Boehringer Ingelheim GmbH
11.13 Eisai Co., Ltd.
11.14 Johnson & Johnson
11.15 Еtоn Віоѕсіеnсе Іnс.
11.16 F. Hoffmann-La Roche Ltd
List of Tables
Table 1 Global Kinase Inhibitors Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Kinase Inhibitors Market Outlook, By Type (2018-2027) ($MN)
Table 3 Global Kinase Inhibitors Market Outlook, By Receptor Tyrosine Kinase Inhibitors (2018-2027) ($MN)
Table 4 Global Kinase Inhibitors Market Outlook, By Platelet-derived Growth Factor Receptors (PDGFR) (2018-2027) ($MN)
Table 5 Global Kinase Inhibitors Market Outlook, By Vascular Endothelial Growth Factor Receptor (VEGFR) (2018-2027) ($MN)
Table 6 Global Kinase Inhibitors Market Outlook, By Anaplastic lymphoma kinase (ALK) (2018-2027) ($MN)
Table 7 Global Kinase Inhibitors Market Outlook, By Human Epidermal Growth Factor Receptor 2 (HER2) (2018-2027) ($MN)
Table 8 Global Kinase Inhibitors Market Outlook, By Estimated Glomerular Filtration Rate (EGFR) (2018-2027) ($MN)
Table 9 Global Kinase Inhibitors Market Outlook, By Non-receptor Tyrosine Kinase Inhibitors (2018-2027) ($MN)
Table 10 Global Kinase Inhibitors Market Outlook, By Mesenchymal Epithelial Transition Growth Factor (c-MET) (2018-2027) ($MN)
Table 11 Global Kinase Inhibitors Market Outlook, By Spleen Tyrosine Kinase (SYK) Inhibitors (2018-2027) ($MN)
Table 12 Global Kinase Inhibitors Market Outlook, By Bruton’s Tyrosine Kinase (BTK) Inhibitors (2018-2027) ($MN)
Table 13 Global Kinase Inhibitors Market Outlook, By BCR-ABL (2018-2027) ($MN)
Table 14 Global Kinase Inhibitors Market Outlook, By Janus Kinase (JAK) Inhibitor (2018-2027) ($MN)
Table 15 Global Kinase Inhibitors Market Outlook, By Angiogenesis Inhibitors (2018-2027) ($MN)
Table 16 Global Kinase Inhibitors Market Outlook, By Protein Kinase C Inhibitors (2018-2027) ($MN)
Table 17 Global Kinase Inhibitors Market Outlook, By RHO Kinase Inhibitors (2018-2027) ($MN)
Table 18 Global Kinase Inhibitors Market Outlook, By Multikinase inhibitors (2018-2027) ($MN)
Table 19 Global Kinase Inhibitors Market Outlook, By Serine/Threonine Kinase Inhibitors (2018-2027) ($MN)
Table 20 Global Kinase Inhibitors Market Outlook, By Tyrosin kinase inhibitors (TKI) (2018-2027) ($MN)
Table 21 Global Kinase Inhibitors Market Outlook, By Threonine kinase inhibitor (2018-2027) ($MN)
Table 22 Global Kinase Inhibitors Market Outlook, By mTOR Kinase Inhibitors (2018-2027) ($MN)
Table 23 Global Kinase Inhibitors Market Outlook, By BRAF Inhibitors (2018-2027) ($MN)
Table 24 Global Kinase Inhibitors Market Outlook, By Cyclin Dependant Kinase Inhibitor (2018-2027) ($MN)
Table 25 Global Kinase Inhibitors Market Outlook, By Aurora Kinase Inhibitors (2018-2027) ($MN)
Table 26 Global Kinase Inhibitors Market Outlook, By MAP/MEK Kinase Inhibitors (2018-2027) ($MN)
Table 27 Global Kinase Inhibitors Market Outlook, By Humanized Monoclonal Antibody (2018-2027) ($MN)
Table 28 Global Kinase Inhibitors Market Outlook, By Chimeric Monoclonal Antibody (2018-2027) ($MN)
Table 29 Global Kinase Inhibitors Market Outlook, By JNK Inhibitors (2018-2027) ($MN)
Table 30 Global Kinase Inhibitors Market Outlook, By PI3K Inhibitors (2018-2027) ($MN)
Table 31 Global Kinase Inhibitors Market Outlook, By Other Types (2018-2027) ($MN)
Table 32 Global Kinase Inhibitors Market Outlook, By Monoclonal Antibody Kinase Inhibitor (2018-2027) ($MN)
Table 33 Global Kinase Inhibitors Market Outlook, By Distribution Channel (2018-2027) ($MN)
Table 34 Global Kinase Inhibitors Market Outlook, By Independent Pharmacies (2018-2027) ($MN)
Table 35 Global Kinase Inhibitors Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
Table 36 Global Kinase Inhibitors Market Outlook, By Online Pharmacies (2018-2027) ($MN)
Table 37 Global Kinase Inhibitors Market Outlook, By Application (2018-2027) ($MN)
Table 38 Global Kinase Inhibitors Market Outlook, By Inflammatory Diseases (2018-2027) ($MN)
Table 39 Global Kinase Inhibitors Market Outlook, By Oncology (2018-2027) ($MN)
Table 40 Global Kinase Inhibitors Market Outlook, By Lung Cancer (2018-2027) ($MN)
Table 41 Global Kinase Inhibitors Market Outlook, By Renal Cell Cancer (2018-2027) ($MN)
Table 42 Global Kinase Inhibitors Market Outlook, By Breast Cancer (2018-2027) ($MN)
Table 43 Global Kinase Inhibitors Market Outlook, By End User (2018-2027) ($MN)
Table 44 Global Kinase Inhibitors Market Outlook, By Scientific Research Labs (2018-2027) ($MN)
Table 45 Global Kinase Inhibitors Market Outlook, By Hospitals (2018-2027) ($MN)
Table 46 Global Kinase Inhibitors Market Outlook, By Academic Institutes (2018-2027) ($MN)
Table 47 Global Kinase Inhibitors Market Outlook, By Healthcare Facilities (2018-2027) ($MN)
Table 48 Global Kinase Inhibitors Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
Table 49 Global Kinase Inhibitors Market Outlook, By Private and Government Research Institutes (2018-2027) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
【免責事項】
https://www.marketreport.jp/reports-disclaimer